First of five Phase 2 trials for AL001 begins in healthy subjects with topline data expected by end of 2025. Preclinical data showed AL001 improved brain absorption with lower blood lithium levels ...

With two weeks in the books, the Bills have moved into Phase 2, inching closer to actual football activity. While Phase 1 consisted only of "meetings, strength and conditioning, and physical ...

The 2025 USHL Phase II Draft is Tuesday, May 6 beginning at 11 Am CT/12 Pm ET, in partnership with Neutral Zone. The Phase I Draft was held on Monday, and the results of all 15 rounds can be found ...

There have been exactly five 200-yard receiving games in Buccaneers' history, including two by future Hall of Famer Mike Evans Tampa Bay Buccaneers Head Coach Todd Bowles spoke to the media after ...

PHILADELPHIA and VANCOUVER, British Columbia, April 16, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the ...

DAVENPORT, Iowa (KWQC) - Davenport Community School District continues to plan for the future of the district’s facilities. That includes the district’s long-range facilities plan which is ...

Metal Gear mastermind Hideo Kojima has revealed in his latest KOJI10 radio show that he will transition to ‘phase 2′ of Kojima Productions following the completion of Death Stranding 2 ...

Spinogenix announced open enrollment for its Phase II trial of SPG302, the first synaptic regenerative therapy for schizophrenia. According to the company, the launch of the Phase II trial comes amid ...

Cerevance’s attempt to unlock the first-line Parkinson's disease market has hit a snag, with solengepras performing no better than placebo in phase 2 when given to people with early, untreated ...

ORLANDO, Fla. — A second phase 2 trial with the tyrosine kinase 2 (TYK2) inhibitor deucravacitinib has met the primary efficacy endpoints for the treatment of the skin manifestations of ...

Phase 2 will raise Northern Lights’ capacity from 1.5 million metric tons per annum (MMtpa) to over 5 MMtpa. The expansion will leverage existing onshore and offshore infrastructures and install ...

A Phase 2 trial demonstrated that the DPP-1 inhibitor HSK31858 significantly reduces acute exacerbations in non-cystic fibrosis bronchiectasis patients compared to placebo, with a 48% reduction at ...